180 related articles for article (PubMed ID: 10680448)
1. Case reports. Invasive pulmonary aspergillosis in non-neutropenic patients treated with liposomal amphotericin B.
Zhirong Y; Wanqing L; Weihua P
Mycoses; 1999; 42(11-12):679-82. PubMed ID: 10680448
[TBL] [Abstract][Full Text] [Related]
2. Successful use of liposome encapsulated amphotericin to treat invasive aspergillosis following failure of conventional amphotericin.
Richards EM; Apperley JF; Marcus RE
Clin Lab Haematol; 1992; 14(2):127-30. PubMed ID: 1633682
[TBL] [Abstract][Full Text] [Related]
3. Chronic necrotizing pulmonary aspergillosis treated by endobronchial amphotericin B.
Bennett MR; Weinbaum DL; Fiehler PC
South Med J; 1990 Jul; 83(7):829-32. PubMed ID: 2196695
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis.
Gavaldà J; Martín MT; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruíz I; Pahissa A
Antimicrob Agents Chemother; 2005 Jul; 49(7):3028-30. PubMed ID: 15980392
[TBL] [Abstract][Full Text] [Related]
5. Case reports. Secondary prophylaxis with liposomal amphotericin B after invasive aspergillosis following treatment for haematological malignancy.
Mele L; Pagano L; Equitani F; Leone G
Mycoses; 2001; 44(5):201-3. PubMed ID: 11486459
[TBL] [Abstract][Full Text] [Related]
6. Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.
Ruijgrok EJ; Fens MH; Bakker-Woudenberg IA; van Etten EW; Vulto AG
Antimicrob Agents Chemother; 2006 May; 50(5):1852-4. PubMed ID: 16641459
[TBL] [Abstract][Full Text] [Related]
7. Long-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice.
Otsubo T; Maruyama K; Maesaki S; Miyazaki Y; Tanaka E; Takizawa T; Moribe K; Tomono K; Tashiro T; Kohno S
Antimicrob Agents Chemother; 1998 Jan; 42(1):40-4. PubMed ID: 9449258
[TBL] [Abstract][Full Text] [Related]
8. [Four cases of pulmonary aspergilloma successfully treated with drug therapy].
Kawana A
Jpn J Antibiot; 2000 Feb; 53(2):91-100; discussion 100-2. PubMed ID: 10896541
[No Abstract] [Full Text] [Related]
9. Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.
Purcell IF; Corris PA
Thorax; 1995 Dec; 50(12):1321-3. PubMed ID: 8553311
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary aspergillosis in an immunocompetent patient.
Ko JP; Kim DH; Shepard JA
J Thorac Imaging; 2002 Jan; 17(1):70-3. PubMed ID: 11828215
[TBL] [Abstract][Full Text] [Related]
11. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of experimental invasive pulmonary aspergillosis in rats with liposomal amphotericin B].
Matsuda H; Kohno S; Miyazaki Y; Mitsutake K; Tanaka K; Maesaki S; Iwamoto M; Hashimoto A; Kaku M; Koga H
Kansenshogaku Zasshi; 1993 Feb; 67(2):102-9. PubMed ID: 8468494
[TBL] [Abstract][Full Text] [Related]
13. Quiz page. Invasive pulmonary aspergillosis presenting with a pulmonary nodule, pneumomediastinum, pneumothorax, and pneumopericardium.
Sengul S; Keven K; Kutlay S; Ergun I; Azap A; Erbay B
Am J Kidney Dis; 2004 Oct; 44(4):A47, E47-9. PubMed ID: 15384032
[No Abstract] [Full Text] [Related]
14. Sinopulmonary aspergillosis in children with hematological malignancy.
Gulen H; Erbay A; Gulen F; Kazanci E; Vergin C; Demir E; Tanac R
Minerva Pediatr; 2006 Jun; 58(3):319-24. PubMed ID: 16832339
[TBL] [Abstract][Full Text] [Related]
15. Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases.
Dornbusch HJ; Urban CE; Pinter H; Ginter G; Fotter R; Becker H; Miorini T; Berghold C
Pediatr Hematol Oncol; 1995; 12(6):577-86. PubMed ID: 8589003
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
Anndo T
Jpn J Antibiot; 2000 Feb; 53(2):84-90; dicussion 90. PubMed ID: 10896540
[No Abstract] [Full Text] [Related]
17. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
18. [Curative antifungal treatment of invasive pulmonary aspergillosis].
Andrès E; Courouau F; Kurtz JE; Limacher JM; Quoix E
Rev Pneumol Clin; 1995; 51(4):228-31. PubMed ID: 7501940
[TBL] [Abstract][Full Text] [Related]
19. Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease.
Cocchi S; Codeluppi M; Guaraldi G; Squillace N; Bedini A; Venturelli C; Esposito R
Scand J Infect Dis; 2005; 37(5):396-8. PubMed ID: 16051585
[TBL] [Abstract][Full Text] [Related]
20. Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients.
Krupova Y; Mistrik M; Bojtarova E; Sejnova D; Ilavska I; Krcmery V
Support Care Cancer; 2001 May; 9(3):209-10. PubMed ID: 11401107
[No Abstract] [Full Text] [Related]
[Next] [New Search]
